# Prognosis Factors in Patients With Primary Central Nervous System Lymphoma

> **NCT05167630** · — · UNKNOWN · sponsor: **Zhengzhou University** · enrollment: 40 (estimated)

## Conditions studied

- PCNSL
- Survival Analysis

## Interventions

- **OTHER:** prognostic marker

## Key facts

- **NCT ID:** NCT05167630
- **Lead sponsor:** Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09-01
- **Primary completion:** 2021-12-15
- **Final completion:** 2021-12-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05167630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05167630, "Prognosis Factors in Patients With Primary Central Nervous System Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05167630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*